Medical approach to ophthalmopathy of Graves' disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004576:Electromyography; D005132:Eye Manifestations; D006111:Graves Disease / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D006145:Guanethidine / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007456:Iodine Isotopes / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013965:Thyroidectomy; D014284:Triiodothyronine
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D007166:Immunosuppressive Agents; D007456:Iodine Isotopes; D009883:Ophthalmic Solutions; D014284:Triiodothyronine; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D006145:Guanethidine